KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Long-Term Debt Repayments (2024)

Inovio Pharmaceuticals' Long-Term Debt Repayments history spans 1 years, with the latest figure at $16.4 million for Q1 2024.

  • For Q1 2024, Long-Term Debt Repayments changed N/A year-over-year to $16.4 million; the TTM value through Dec 2024 reached $16.4 million, changed N/A, while the annual FY2024 figure was $16.4 million, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q1 2024 was $16.4 million at Inovio Pharmaceuticals.
  • Across five years, Long-Term Debt Repayments topped out at $16.4 million in Q1 2024 and bottomed at $16.4 million in Q1 2024.